A common virus once thought harmless to humans might be linked to Parkinson's disease, a new study says. The germ, Human Pegivirus (HPgV), was found in half the autopsied brains of patients with ...

A new Stanford Medicine study reveals a promising approach to slowing Parkinson's disease by targeting overactive LRRK2 enzymes with an MLi-2 inhibitor, showing neuron restoration in mice.

Researchers believe the HPgV virus could be an environmental trigger or contributor to Parkinson's disease.

Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.

A team of Chicago area scientists discovered that the human pegivirus, a blood-borne virus otherwise not known to cause any specific disease, may be associated with Parkinson’s disease and ma… ...

While some cases of Parkinson’s disease are genetic, the vast majority have no known cause. Now, scientists have discovered that a virus that has flown under the radar for years might be a ...

Human Pegivirus may be environmental trigger for Parkinson’s disease Northwestern Medicine find HPgV in brain samples of people with Parkinson’s, not in those without ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford scientists reporting improvement in neuron communication in mice.

Video. A unique programme in Rio de Janeiro is helping people with Parkinson’s disease manage their symptoms through the art of capoeira.

Latest medical research on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, medication and more.

Parkinson's disease is a progressive and common neurodegenerative condition, typically characterized by involuntary shaking, stiffness, and slow movement.

A groundbreaking new study out of Northwestern Medicine may offer new hope for the more than one million Americans living with Parkinson’s disease.